US-based enterprise cybersecurity software producer CounterTack has raised $10m in funding from investors including industrial product maker Siemens, defence technology provider ManTech, conglomerate Mitsui and telecommunications equipment producer Alcatel-Lucent.
The round also featured investment bank Goldman Sachs, TenEleven Ventures, Fairhaven Capital, Razor’s Edge Ventures and the Singapore state-owned EDBI, while Siemens participated through its corporate venturing unit, Siemens Venture Partners.
CounterTack produces real-time, big data-equipped technology that detects and responds to attacks, rootkits, malware and persistent threats. The funding will support the growth of its Sentinel and Digital DNA products in the US and Asia Pacific region.
Neal Creighton, CounterTack’s chief executive, said: “CounterTack will unveil multiple new strategic initiatives and alliances over the next six months, as well as a major new partner to bring more scale to our US federal business.
“We have a great opportunity before us, and we are eager to capitalise on the market’s needs for innovative and customisable endpoint protection.”
The company has now raised approximately $64m altogether, closing a $17.9m series C round in September 2015 with funding from Siemens Venture Partners, Mitsui, Alcatel-Lucent, Goldman Sachs, TenEleven, Razor’s Edge, Fairhaven, EDBI and OnPoint Technologies.
Siemens Venture Capital, Goldman Sachs, Fairhaven, Razor’s Edge and OnPoint had previously taken part in CounterTack’s $20m series B round in mid-2014.